[Federal Register Volume 60, Number 62 (Friday, March 31, 1995)]
[Rules and Regulations]
[Pages 16570-16571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7865]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Part 510
Animal Drugs, Feeds, and Related Products; Change of Sponsor Name
and Address
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor name and address from
Kabi Pharmacia, Inc., to Pharmacia, Inc.
EFFECTIVE DATE: March 31, 1995.
FOR FURTHER INFORMATION CONTACT: Benjamin A. Puyot, Center for
Veterinary Medicine (HFV-130), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-594-1646.
SUPPLEMENTARY INFORMATION: Kabi Pharmacia, Inc., 800 Centennial Ave.,
Piscataway, NJ 08854, has informed FDA of a change of sponsor name and
address from Kabi Pharmacia, Inc., to Pharmacia Inc., P.O. Box 16529,
Columbus, OH 43216-6529. Accordingly, the agency is amending the
regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change of
sponsor name and address.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements. [[Page 16571]]
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 706, 721 of
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351,
352, 353, 360b, 371, 376e).
2. Section 510.600 is amended in the table in paragraph (c)(1) by
removing the entry for ``Kabi Pharmacia, Inc.,'' and alphabetically
adding a new entry for ``Pharmacia, Inc.,'' and in the table in
paragraph (c)(2) in the entry for ``000016'' by revising the sponsor
name and address to read as follows:
Sec. 510.600 Names, addresses, and drug labeler codes of sponsors of
approved applications.
* * * * *
(c) * * *
(1) * * *
------------------------------------------------------------------------
Drug
Firm name and address labeler
code
------------------------------------------------------------------------
* * * * *
Pharmacia, Inc., P.O. Box 16529, Columbus, OH 43216-6529....... 000016
* * * * *
------------------------------------------------------------------------
(2) * * *
------------------------------------------------------------------------
Drug
labeler Firm name and address
code
------------------------------------------------------------------------
* * * * *
000016. Pharmacia, Inc., P.O. Box 16529, Columbus, OH 43216-6529
* * * * *
------------------------------------------------------------------------
Dated: March 21, 1995.
Robert C. Livingston,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. 95-7865 Filed 3-30-95; 8:45 am]
BILLING CODE 4160-01-F